Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06793059
NA
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
Sponsor: Jacobs institute
View on ClinicalTrials.gov
Summary
The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms
Key Details
Gender
All
Age Range
22 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2025-01-01
Completion Date
2027-01-01
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Interventions
DEVICE
SHIELD
Pipeline SHIELD device under study
Locations (1)
Jacobs Institute
Buffalo, New York, United States